Select Publications

Book Chapters

Wark G; Samocha-Bonet D; Ghaly S; Danta M, 2023, 'The role of nutrition in inflammatory bowel disease: Disease associations, management of active disease and maintenance of remission', in Encyclopedia of Human Nutrition: Volume 1-4, Fourth Edition, pp. 669 - 697,

Danta M, 2012, 'Hepatobiliary Disease', in Hunter's Tropical Medicine and Emerging Infectious Disease Expert Consult - Online and Print, Elsevier Health Sciences, pp. 28 - 34

Journal articles

Yeoh YKJ; Dore GJ; Lockart I; Danta M; Flynn C; Blackmore C; Levy MT; George J; Alavi M; Hajarizadeh B, 2024, 'Temporal change in aetiology and clinical characteristics of hepatocellular carcinoma in a large cohort of patients in New South Wales, Australia', Internal Medicine Journal, 54, pp. 602 - 612,

Bin Usman Shah SH; Alavi M; Hajarizadeh B; Matthews GV; Martinello M; Danta M; Amin J; Law MG; George J; Valerio H; Dore GJ, 2024, 'Corrigendum to “Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales” [JHEP Reports 4 (2022)] (JHEP Reports (2022) 4(10), (S2589555922001240), (10.1016/j.jhepr.2022.100552))', JHEP Reports, 6,

Wark G; Kaakoush NO; Samocha-Bonet D; Ghaly S; Danta M, 2024, 'P1233 Serum insulin is associated with c-reactive protein and gut microbial diversity in inflammatory bowel disease', Journal of Crohn's and Colitis, 18, pp. i2183 - i2183,

Qin S; Chen M; Cheng AL; Kaseb AO; Kudo M; Lee HC; Yopp AC; Hsiehchen D; Zhou J; Wang L; Wang Y; Wen X; Heo J; Tak WY; Nakamura S; Numata K; Uguen T; Cha E; Hack SP; Lian Q; Ma N; Spahn JH; Wu C; Chow PKH; Thompson A; Danta M; Poursoltan P; Kiberu A; Chittajallu R; Sood S; Stauber R; Pinter M; Peck-Radosavljevic M; Decaestecker J; Cuyle PJ; Verset G; Van Vlierberghe H; De Azevedo S; Andrade L; Cunha Júnior A; Faria L; Yen CT; Colli L; Asselah J; Kavan P; Marquez V; Brahmania M; Li Q; Xing B; Guo Y; Chen Z; Zhao H; Peng T; Wang L; Wang L; Liu H; Wu F; Qin L; Zheng Q; Ying J; Li H; Wen T; Liu Y; Wang B; Bai Y; He Y; Zhao H; Zhou D; Dai C; Teng G; Cui S; Gao Y; Zhang X; Lu Z; Yin T; Ding Y; Jia W; Xia Y; Sun B; Xia Q; Yuan Y; Sun H; Shi X; Guzmán A; Corrales L; Kral Z; Priester P; Kubala E; Blanc JF; Bourliere M; Peron JM; Borg C; Bronowicki JP; Ganne N; Decaens T, 2023, 'Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial', The Lancet, 402, pp. 1835 - 1847,

Jacob R; Danta M; Feller R; Williams D; Sanagapalli S, 2023, 'Empiric Esophageal Dilatation for Solid-Food Dysphagia: Presence of Mucosal Tear on Relook Endoscopy Predicts Symptomatic Response', American Journal of Gastroenterology, 118, pp. 1888 - 1890,

Shalaby N; Samocha-Bonet D; Kaakoush NO; Danta M, 2023, 'The Role of the Gastrointestinal Microbiome in Liver Disease', Pathogens, 12,

Crane H; Danta M, 2023, 'Aspirin, chronic hepatitis B (CHB) and hepatocellular carcinoma (HCC)-will there ever be enough data?', Ann Transl Med, 11, pp. 293,

Chaganti J; Zeng G; Tun N; Lockart I; Abdelshaheed C; Cysique L; Montagnese S; Brew BJ; Danta M, 2023, 'Novel magnetic resonance KTRANS measurement of blood-brain barrier permeability correlated with covert HE', Hepatology Communications, 7,

Zeng G; Krishnamurthy S; Pires AS; Guller A; Tun N; Chaganti J; Lockart I; Montagnese S; Brew B; Guillemin G; Danta M; Heng B, 2023, 'Activation of the kynurenine pathway potentially underlies neurodegeneration in patients with covert hepatic encephalopathy', Journal of Hepatology, 78, pp. S263 - S264,

Wilson S; Joseph J; Danta M; Rabbolini DJ, 2023, 'Viscoelastometry to Manage Bleeding in Liver Disease.', Cureus, 15, pp. e41401,

Prince DS; Schlaphoff G; Davison SA; Huo YR; Xiang H; Chan MV; Lee AU; Thailakanathan C; Jebeili H; Rogan C; Al-Omary A; Gupta S; Lockart I; Tiwari N; Clark-Dickson M; Hillhouse JW; Laube R; Chang J; Nguyen V; Danta M; Cheng R; Strasser SI; Zekry A; Levy MT; Chan C; Liu K, 2022, 'Selective internal radiation therapy for hepatocellular carcinoma: A 15-year multicenter Australian cohort study', Journal of Gastroenterology and Hepatology (Australia), 37, pp. 2173 - 2181,

Shah SHBU; Alavi M; Hajarizadeh B; Matthews GV; Martinello M; Danta M; Amin J; Law MG; George J; Valerio H; Dore GJ, 2022, 'Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales', JHEP Reports, 4,

Lockart I; Yeo MGH; Hajarizadeh B; Dore G; Danta M; Abe K; Carrat F; Lusivika-Nzinga C; Degasperi E; Di Marco V; Hou J; Howell J; Janjua NZ; Wong S; Kumada T; Lleo A; Persico M; Lok AS; Wei L; Yang M; Nabatchikova E; Nguyen MH; Antonio Pineda J; Reig M; Shiha G; Yu ML; Tsai PC, 2022, 'HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysis', Hepatology, 76, pp. 139 - 154,

Blackwood GA; Danta M; Gett R, 2022, 'Acute Cytomegalovirus Infection Associated With Splenic Infarction: A Case Report and Review of the Literature', CUREUS JOURNAL OF MEDICAL SCIENCE, 14,

Jacob R; Danta M, 2022, 'Pharmacotherapeutic strategies for hepatitis B and hepatitis C coinfection', Expert Opinion on Pharmacotherapy, 23, pp. 465 - 472,

Lockart I; Hajarizadeh B; Buckley N; Davison S; Prakoso E; Levy MT; George J; Dore GJ; Danta M, 2021, 'All-cause hepatocellular carcinoma survival in the era of direct-acting antiviral therapy', Journal of Gastroenterology and Hepatology (Australia), 36, pp. 3515 - 3523,

Snaith JR; Danta M; Greenfield JR, 2021, 'Metabolic dysfunction-associated fatty liver disease and insulin resistance in type 1 diabetes', The Lancet Gastroenterology and Hepatology, 6, pp. 985 - 986,

Danta M; Tan RZH; Lockart I; Abdel Shaheed C, 2021, 'Editorial: aspirin and NSAID for chemoprevention of hepatocellular carcinoma – ready for their use? Authors' reply', Alimentary Pharmacology and Therapeutics, 54, pp. 852 - 853,

Tan RZH; Lockart I; Abdel Shaheed C; Danta M, 2021, 'Systematic review with meta-analysis: The effects of non-steroidal anti-inflammatory drugs and anti-platelet therapy on the incidence and recurrence of hepatocellular carcinoma', Alimentary Pharmacology and Therapeutics, 54, pp. 356 - 367,

Mak G; Zaunders JJ; Bailey M; Seddiki N; Rogers G; Leong L; Phan TG; Kelleher AD; Koelsch KK; Boyd MA; Danta M, 2021, 'Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection', Frontiers in Immunology, 12, pp. 688886,

Lockart I; Hajarizadeh B; Alavi M; Davison S; Prakoso E; Levy MT; George J; Dore GJ; Danta M, 2021, 'Hepatitis C virus cure before hepatocellular carcinoma diagnosis is associated with improved survival', Journal of Viral Hepatitis, 28, pp. 710 - 718,

Seddiki N; Zaunders J; Phetsouphanh C; Brezar V; Xu Y; McGuire HM; Bailey M; McBride K; Hey-Cunningham W; Munier CML; Cook L; Kent S; Lloyd A; Cameron B; De St Groth BF; Koelsch K; Danta M; Hocini H; Levy Y; Kelleher AD, 2021, 'CD73+ CD127high long-term memory CD4 T cells are highly proliferative in response to recall antigens and are early targets in hiv-1 infection', International Journal of Molecular Sciences, 22, pp. 1 - 28,

Wark G; Samocha-Bonet D; Ghaly S; Danta M, 2021, 'The role of diet in the pathogenesis and management of inflammatory bowel disease: A review', Nutrients, 13, pp. 1 - 26,

Ambati C; Danta M; Boshell D; Ende J; Williams D; Chaganti J, 2021, 'The Promise of Percutaneous Transhepatic Variceal Embolization for Both Gastroesophageal and Ectopic Varices—An Australian Case Series', Journal of Clinical Interventional Radiology ISVIR, 5, pp. 03 - 10,

Dore GJ; Danta M; Matthews GV, 2020, 'Hepatocellular carcinoma risk with antivirals for chronic hepatitis B: no longer confounding', The Lancet Gastroenterology and Hepatology, 5, pp. 1028 - 1029,

Danta M; Zeng G; Montagnese S, 2020, 'Author response: Meta-analysis of magnetic resonance spectroscopy in the diagnosis of hepatic encephalopathy', Neurology, 95, pp. 985,

Htet TD; Godneva A; Liu Z; Chalmers E; Kolobkov D; Snaith JR; Richens R; Toth K; Danta M; Hng TM; Elinav E; Segal E; Greenfield JR; Samocha-Bonet D, 2020, 'Rationale and design of a randomised controlled trial testing the effect of personalised diet in individuals with pre-diabetes or type 2 diabetes mellitus treated with metformin', BMJ Open, 10, pp. e037859,

Tun N; Chaganti J; Zeng G; Lockart I; Montagnese S; Brew B; Danta M, 2020, 'Prospective study of magnetic resonance spectroscopy identifies specific metabolic changes in covert hepatic encephalopathy', JOURNAL OF HEPATOLOGY, 73, pp. S737 - S737,

Myint NPST; Zaw TT; Sain K; Waiyan S; Danta M; Cooper D; Aung NM; Kyi MM; Hanson J, 2020, 'Sequential Helicobacter pylori eradication therapy in Myanmar; a randomized clinical trial of efficacy and tolerability', Journal of Gastroenterology and Hepatology (Australia), 35, pp. 617 - 623,

Zeng G; Penninkilampi R; Chaganti J; Montagnese S; Brew BJ; Danta M, 2020, 'Meta-analysis of magnetic resonance spectroscopy in the diagnosis of hepatic encephalopathy', Neurology, 94, pp. e1147 - e1156,

Smith FC; Stocker SL; Danta M; Carland JE; Kumar SS; Liu Z; Greenfield JR; Braithwaite HE; Cheng TS; Graham GG; Williams KM; Day RO, 2020, 'The safety and pharmacokinetics of metformin in patients with chronic liver disease', Alimentary Pharmacology and Therapeutics, 51, pp. 565 - 575,

He S; Lockart I; Alavi M; Danta M; Hajarizadeh B; Dore GJ, 2020, 'Systematic review with meta-analysis: effectiveness of direct-acting antiviral treatment for hepatitis C in patients with hepatocellular carcinoma', Alimentary Pharmacology and Therapeutics, 51, pp. 34 - 52,

Dai P; Furlong T; Gracie G; Huang ML; Yang T; Wu KHC; Danta M; Wong M; Williams A; March L; Hetherington M; Heyworth-Smith D; Phan TG, 2019, 'Autoinflammation Masquerading as Autoimmunity in an Adult with Heterozygous p.E250K PSTPIP1 Mutation', Journal of Clinical Immunology, 39, pp. 519 - 522,

Zaunders J; Dyer WB; Churchill M; Munier CML; Cunningham PH; Suzuki K; McBride K; Hey-Nguyen W; Koelsch K; Wang B; Hiener B; Palmer S; Gorry PR; Bailey M; Xu Y; Danta M; Seddiki N; Cooper DA; Saksena NK; Sullivan JS; Riminton S; Learmont J; Kelleher AD, 2019, 'Possible clearance of transfusion-acquired nef/LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Delta 32 heterozygous and HLA-B57 genotype', JOURNAL OF VIRUS ERADICATION, 5, pp. 73 - 83,

Bartlett SR; Applegate TL; Jacka BP; Martinello M; Lamoury FMJ; Danta M; Bradshaw D; Shaw D; Lloyd AR; Hellard M; Dore GJ; Matthews GV; Grebely J, 2019, 'A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015', Journal of the International AIDS Society, 22, pp. e25222,

Lockart I; Matthews GV; Danta M, 2019, 'Sexually transmitted hepatitis C infection: The evolving epidemic in HIV-positive and HIV-negative MSM', Current Opinion in Infectious Diseases, 32, pp. 31 - 37,

Weber MF; Marshall HM; Rankin N; Duffy S; Fong KM; Dunlop K; Humphreys L; Smit AK; Cust AE; Taylor N; Mitchell G; Kang YJ; Tucker K; Jenkins M; Macrae F; Lockart I; Danta M; Armstrong BK; Howe M, 2019, 'Cancer screening in Australia: Future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancers', Public Health Research and Practice, 29,

Cosorich I; McGuire HM; Warren J; Danta M; King C, 2019, 'CCR9 expressing T helper and T follicular helper cells exhibit site-specific identities during inflammatory disease', Frontiers in Immunology, 10, pp. 2899,

Chia XX; Cherepanoff S; Danta M; Furlong T, 2018, 'Successful treatment of HCV-related glomerulonephritis with sofosbuvir and daclatasvir', Nephrology, 23, pp. 379 - 380,

Deenick EK; Morey A; Danta M; Emmett L; Fay K; Gracie G; Ma CS; Macintosh R; Smith SABC; Sasson SC; Sewell WA; Cowley M; Tangye SG; Kelleher AD; Phan TG, 2018, 'Reversible Suppression of Lymphoproliferation and Thrombocytopenia with Rapamycin in a Patient with Common Variable Immunodeficiency', Journal of Clinical Immunology, 38, pp. 159 - 162,

Ma CKK; Danta M; Day R; Ma DDF, 2018, 'Dealing with the spiralling price of medicines: issues and solutions', Internal Medicine Journal, 48, pp. 16 - 24,

Liu Q; Jarvis S; Tang K; Danta M; Nair P; Miranda S; Rabbolini D; Joseph J, 2018, 'Pre-procedural rotational thromboelastometry (ROTEM) guided transfusion in liver failure patients', Pathology, 50, pp. S105 - S105,

Waziry R; Hajarizadeh B; Grebely J; Amin J; Law M; Danta M; George J; Dore GJ, 2017, 'Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression', Journal of Hepatology, 67, pp. 1204 - 1212,

Danta M; Barber DA; Zhang HP; Lee-Ng M; Baumgart SWL; Tsai VWW; Husaini Y; Saxena M; Marquis CP; Errington W; Kerr S; Breit SN; Brown DA, 2017, 'Macrophage inhibitory cytokine-1/growth differentiation factor-15 as a predictor of colonic neoplasia', Alimentary Pharmacology and Therapeutics, 46, pp. 347 - 354,

Newsum AM; Stolte IG; Van Der Meer JT; Schinkel J; Van Der Valk M; Vanhommerig JW; Buvé A; Danta M; Hogewoning A; Prins M, 2017, 'Development and validation of the HCV-MOSAIC risk score to assist testing for acute hepatitis C virus (HCV) infection in HIV-infected men who have sex with men (MSM)', Eurosurveillance, 22, pp. 30540,

Danta M; Ghinea N, 2017, 'The complex legal and ethical issues related to generic medications. Viral hepatitis: a case study', JOURNAL OF VIRUS ERADICATION, 3, pp. 77 - 81,

Ghinea N; Lipworth W; Day R; Hill A; Dore GJ; Danta M, 2017, 'Importation of generic hepatitis C therapies: bridging the gap between price and access in high-income countries', The Lancet, 389, pp. 1268 - 1272,

Baumgart S; Barber DA; Zhang HP; Lee-Ng M; Breit S; Brown D; Danta M, 2017, 'Macrophage Inhibitory Cytokine 1 (MIC1/GDF15) as a Novel Serum Biomarker of Colonic Neoplasia', Gastroenterology, 152, pp. S1030 - S1030,

Back to profile page